Clin2
NCT06189755Possibly a fitRecruiting

MicroRNA markers for sleep apnea

Obstructive Sleep Apnea

Part of Brain & nervous system, Lungs & breathing clinical trials.

This trial is studying tiny molecules in the blood (called microRNAs) to see if they can help diagnose or monitor obstructive sleep apnea. It compares people with moderate to severe sleep apnea who are starting PAP therapy with people who do not have sleep apnea.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are between 18 and 75 years old.
  • You either have moderate to severe sleep apnea (AHI 15 or higher) and are willing to start using PAP therapy, or you do NOT have sleep apnea (AHI less than 5).
  • You are not currently using a PAP machine or other sleep apnea treatment.
  • You do not work night shifts.
  • You sleep at least 5 hours per night on weeknights.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07723144Recruiting
Identifying sleep apnea biomarkers

This study compares blood samples from people with moderate-to-severe sleep apnea and those without sleep apnea to find markers that could help diagnose or treat the condition. Half of those with sleep apnea will start CPAP therapy right away, while others wait before starting.

Bialystok, Podlaskie Voivodeship
NCT06608888Recruiting
Brain chemical study for sleep apnea and snoring

This study looks at how a brain chemical called 5-HT7 affects sleep apnea by testing different groups: people with sleep apnea, people who snore, and healthy volunteers. It aims to find new ways to help regulate breathing during sleep.

Beijing, Beijing Municipality
NCT05539716Recruiting
Treating sleep apnea to study effects on metabolism

This study tests a sleep apnea treatment approach and looks at how it may affect your body’s metabolism. You may be eligible if you’re an adult with sleep apnea and meet health and medication rules, and possibly if you already use a PAP machine regularly.

Miami, Florida
NCT05558501Recruiting· Phase 1/Phase 2
Intermittent low-oxygen therapy for sleep apnea and health risks

This early-stage study tests a treatment that briefly reduces oxygen during sleep to improve “plasticity,” with the goal of helping people with obstructive or mixed sleep apnea. It also looks at related conditions like high blood pressure and pre-diabetes or cholesterol problems, especially in people who haven’t tried CPAP yet.

Detroit, Michigan
NCT06319482Recruiting
Testing a new sleep apnea therapy device

This study tests a new proactive therapy for people recently diagnosed with moderate or severe sleep apnea. It aims to see how well patients stick with the treatment outside of a sleep lab.

Halifax, Nova Scotia
NCT07539870Not yet recruiting
Mouth exercises and CPAP for mild to moderate sleep apnea

This trial tests whether combining mouth and throat exercises with a CPAP machine (a device that gently pushes air to keep your airway open while you sleep) can help people with mild-to-moderate obstructive sleep apnea breathe better at night. The study aims to see if this combination approach is effective and safe for you.

Hear when a new Obstructive Sleep Apnea trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.